购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

IL-17A Protein, Human, Recombinant V2

一键复制产品信息
TargetMol | SPRIL-17A Protein, Human, Recombinant V2
产品编号 TMPY-02886U

IL-17A Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is Q16552.

IL-17A Protein, Human, Recombinant V2

IL-17A Protein, Human, Recombinant V2

一键复制产品信息
TargetMol | SPRIL-17A Protein, Human, Recombinant V2
产品编号 TMPY-02886U
IL-17A Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is Q16552.
规格价格库存数量
大包装 & 定制
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多

产品信息

生物活性
Immobilized Human AXL-His at 10μg/ml (100 μl/well) can bind Human GAS6-His*.*: Biotinylated by NHS-biotin prior to testing The ED50 of Recombinant Human GAS6-His* is 0.04466 ug/ml. (Regularly tested)
产品描述
IL-17A Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is Q16552.
种属
Human
表达系统
E. coli
蛋白编号Q16552
别名
白介素,interleukin 17A,IL-17A,IL-17,IL17,CTLA-8,CTLA8
蛋白构建
Gly24-Ala155
蛋白纯度
> 95% as determined by SDS-PAGE
分子量15.26 kDa (Predicted); 16 kDa (Reducing conditions)
内毒素< 1.0 EU/μg of the protein as determined by the LAL method.
蛋白性状Lyophilized powder
缓冲液Lyophilized from a 0.2 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.4.
存储
Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景
Interleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation.

计算器

  • 复溶 计算器
  • 重组蛋白稀释 计算器
  • 比活力 计算器

技术支持

请阅读 重组蛋白用户指南 了解更多具体信息.

关键词